Last update Aug. 29, 2021

ATC B01AC: Antithrombotic agents: Platelet aggregation inhibitors

Very Low risk.

Very Low Risk

More information

Low Risk.

Low Risk

More information

High Risk.

High Risk

More information

Very High Risk.

Very High Risk

More information

Very Low risk.

Very Low Risk

More information

Low Risk.

Low Risk

More information

High Risk.

High Risk

More information

Very High Risk.

Very High Risk

More information

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

DONATE NOW

Groups related with ATC B01AC: Antithrombotic agents: Platelet aggregation inhibitors

ATC B01AA: Antithrombotic agents: Vitamin K antagonists (4 products)
ATC B01AB: Antithrombotic agents: Heparin group (12 products)
ATC B01AD: Antithrombotics: Enzymes (4 products)
ATC B01AE: Antithrombotic agents: direct thrombin inhibitors (4 products)
ATC B01AF & AX: Anti-thrombotic: Direct factor Xa inhibitors & other agents (5 products)
NoATC FAR-B: Direct oral anticoagulants (DOACs) (4 products)

Total visits

5,963

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM